IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.
In the News
Accepted poster presentation at the Society of Investigative Dermatology: “Identifying a core domain set to assess psoriasis in clinical trials: Delphi survey of patients and healthcare professionals from the International Dermatology Outcome Measures Psoriasis Initiative”.
International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.
The group’s inaugural meeting in Boston established a need for consistent core measurements when evaluating clinical trials and therapeutic effectiveness. At the second meeting in Toronto, the group began discussing what elements are critical to be measured in psoriatic clinical trials and in clinical practice. The third meeting focused on what patients and European regulators were interested in seeing in measures.
2018 IDEOM Call for Abstracts
Washington, DC - May 4-5, 2018
Eligibility: Stakeholders, trainees, and Industry representatives at any level are eligible to submit an abstract
Submission deadline: April 12, 2018
Submission: Submit abstract by email to firstname.lastname@example.org along with attached application form.
A Note from our President:
"The true finish line is when the patient gets to the right doctor and the right treatment and their disease has minimal to no impact on their quality of life."
-Alice Gottlieb, MD, PhD
F083: Red Flags and Emergencies in Dermatology. The Use of Biologic Agents and Chemotherapy in Generalized Pustular
and Erythrodermic Psoriasis
Saturday, February 17, 2018
IDEOM activities will be presented at GRAPPA
Sunday, February 18, 2018 12:15 pm to 1:00 pm
Marriott Marquis Grand Ballroom 2
IGA x BSA as a Practical Approach to Assessing Psoriasis at the poster session
Saturday, February 17, 2018 1:55 pm to 2 pm
IDEOM's Work and Opportunities for Collaboration at the NAAF Meeting
Saturday, February 17,2018 1:15-1:45
Rancho Santa Fe Room
PSA: New and Emerging Treatments will be presented at
S041: Translating Evidence into Practice: Psoriasis Guidelines
Sunday, February 18, 2018 2:10 pm
F145: -Research gaps in psoriasis: opportunities for future studies and development of new outcome measures for clinical trials
Monday, February 19, 2018 3:30 to 5:30 pm